Dengue Vaccine Available In Passport Health’s Mexico Clinics September 13, 2016 By Will Sowards Leave a Comment Passport Health is pleased to announce that Dengvaxia®, the first WHO-approved dengue fever vaccine, is available in our Mexico clinics. Dengue is a mosquito-borne disease that affects nearly 400 million people each year across the globe. Approximately a quarter of these individuals will die from the disease. Symptoms of dengue include: Severe headache Joint, bone or muscle pain Mild bleeding Severe abdominal pain or vomiting Circulatory failure, shock and possibly death The vaccine is as a potentially life saving item, especially in dengue-affected regions. Dengvaxia® was first licensed in Mexico and is approved for use in people 9- to 45-years-old. Administration is in a 3-dose series with boosters at six and twelve months. It is not yet clear when, or if, re-vaccination will be required. Passport Health’s Mexico clinics are its only clinics with the vaccine in-stock for travelers. The vaccine will become available in the United States once it has been approved. Subscribe to our blog to learn more. Until the vaccine becomes available in the United States, health professionals recommend the following to avoid infection: Wear long sleeves or pants and treating your clothes with repellents like permethrin. Using EPA-registered mosquito repellents and mosquito nets when necessary. Avoiding areas with standing water especially during times with high mosquito activity. To learn more about dengue and how to prevent it, see our dengue prevention page. To learn more about the dengue vaccine, see our dengue vaccination page. Are you planning a trip to a dengue-affected region? Schedule a travel consultation with your local Passport Health clinic by calling or booking online now!